Immediate Impact
1 from Science/Nature 65 standout
Citing Papers
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Fumiyoshi Ohyanagi being referenced
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer
2015
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Fumiyoshi Ohyanagi | 663 | 556 | 259 | 68 | 1.1k | |
| Lara Pijuán | 663 | 556 | 303 | 72 | 1.2k | |
| Ho Jung An | 462 | 545 | 263 | 70 | 1.1k | |
| Jing Li | 469 | 403 | 264 | 62 | 1.0k | |
| Atsushi Osoegawa | 376 | 578 | 330 | 87 | 1.1k | |
| Changsong Qi | 385 | 642 | 258 | 68 | 1.1k | |
| Ji‐Young Choe | 573 | 691 | 282 | 53 | 1.2k | |
| Jiuda Zhao | 548 | 722 | 330 | 85 | 1.3k | |
| Tomasz Świtaj | 660 | 595 | 282 | 104 | 1.4k | |
| Michihiko Tajiri | 586 | 343 | 345 | 71 | 1.0k | |
| Luisa Carbognin | 393 | 906 | 327 | 65 | 1.3k |
All Works
Loading papers...